Immunovant IMVT
NASDAQ IMVT
$33.74 +0.09 (+0.27%)
As of: Oct 2, 2026 · 11:41 AM EDT

Immunovant (IMVT) Change in Taxes (2019 - 2021)

Updated

Immunovant (IMVT) recorded Change in Taxes of $2.39 million in FY2026 (year ended Mar 31, 2026), up 814.2% from $261,000 in FY2025.

Analysis

Immunovant (IMVT) Change in Taxes (2019 - 2021) Analysis & Trends

Starting with FY2019, Immunovant's Change in Taxes history includes 8 fiscal years.

  • Annual Change in Taxes has a five-year compound annual growth rate of 36.0% (FY2021 to FY2026).
  • The FY2026 figure is the highest annual Change in Taxes in data going back to FY2019.
  • Per Business Quant data, IMVT's Change in Taxes was $261,000 in FY2025, -$19,000 in FY2024, -$461,000 in FY2023 and $85,000 in FY2022 (-83.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.22 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -1.53 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -131.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 171.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunovant 6.97 Bn 6.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 67,000.00
Dec 31, 2020 441,000.00
Sep 30, 2020 16,000.00
Jun 30, 2020 -12,000.00
Mar 31, 2020 -119,000.00
Dec 31, 2019 150,000.00
Sep 30, 2019 -22,000.00
Jun 30, 2019 -22,000.00
Mar 31, 2019 -7,000.00
API Access

Immunovant Change in Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-taxes&ticker=IMVT&period=max&api_key=YOUR_API_KEY